In this Demystifying Medicine video from McMaster University, learn more about idiopathic pulmonary fibrosis (IPF), a scleroderma-related condition that currently has no known cause. Back in February, researchers presented a study investigating the therapeutic effect of the monoclonal antibody CM-101 in animal models of systemic sclerosis (SSc) and…
Gallery
Social Clips
Scleroderma and the GI Tract
In this video by the Scleroderma Foundation, Greater Chicago Chapter, watch Michael Brown, MD, Professor of Medicine, Rush University Medical Center, talk about scleroderma and the gastrointestinal tract (GI). Read the latest scleroderma and gastrointestinal (GI) problems news here: https://bit.ly/1ZGMEEZ…
Recent Posts
- Signaling pathway in skin cells may drive scleroderma inflammation
- Genetic links to systemic sclerosis may differ by sex, new study finds
- Autoantibodies tied to symptoms, complications in scleroderma study
- Liver enzyme levels help diagnose autoimmune hepatitis in SSc: Study
- Stem cell transplant safely eases scleroderma symptoms for teen
- New study flags existing medications as possible scleroderma treatments
- Anti-CD146 antibodies may signal occupational exposure in SSc: Study
- New SSc drug safely cuts Raynaud’s attack duration, eases symptoms
- Carbon dioxide hand baths may help in SSc-related Raynaud’s, study finds
- More SSc-ILD patients receive early treatment, new study finds